{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-046392","form_type":"8-K","ticker":"IVF","cik":"0001417926","company_name":"INVO Fertility, Inc.","filed_at":"2023-12-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.998447+00:00","generated_at":"2026-06-07T06:17:44.851692+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"INVO reduces warrant exercise price to $2.85 for 276,000 shares after shareholder approval","bullets":["Amendment executed Dec 28, 2023 lowers exercise price from $12.60 to $2.85 per share for 276,000 shares.","Original warrant from March 2023 at $0.63 per share adjusted after 1-for-20 reverse split in July 2023.","Reduction aligns with per-unit price of $2.85 from August 2023 public offering, previously agreed in SPA Amendment.","Shareholder approval obtained at Dec 26, 2023 Annual Meeting per Nasdaq Listing Rule 5635(d)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-046392","json":"https://secwatch.observer/filing/0001493152-23-046392.json","markdown":"https://secwatch.observer/filing/0001493152-23-046392.md","text":"https://secwatch.observer/filing/0001493152-23-046392.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223046392/0001493152-23-046392-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223046392/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T06:17:44.851692+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6f26fdb2be7d5f8f5207b7bada5d84406218c7b7","claim":"INVO Fertility, Inc. amended Amendment to Common Stock Purchase Warrant with a certain institutional investor (effective 2023-12-28).","evidence_excerpt":"On December 28, 2023, INVO Bioscience, Inc. (the “Company”) entered into an Amendment to Common Stock Purchase Warrant (the “Amendment”) with s certain institutional investor to amend that certain Common Stock Purchase Warrant dated March 27, 2023 issued by the Company to such investor (the “Original Warrant”) to reduce the exercise price under Section 2(b) thereunder to $2.85 per share.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223046392/0001493152-23-046392-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"a certain institutional investor"},{"label":"Effective","value":"2023-12-28"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}